Approval for revision of the physician and patient labels to include updates on the post market adverse event experience with the device.
Device | ELEVESS |
Classification Name | Implant, Dermal, For Aesthetic Use |
Generic Name | Implant, Dermal, For Aesthetic Use |
Applicant | Anika Therapeutics, Inc. |
Date Received | 2009-09-08 |
Decision Date | 2010-05-24 |
PMA | P050033 |
Supplement | S008 |
Product Code | LMH |
Advisory Committee | General & Plastic Surgery |
Supplement Type | Special (immediate Track) |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | Anika Therapeutics, Inc. 32 Wiggins Avenue bedford, MA 01730 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P050033 | | Original Filing |
S020 |
2015-09-29 |
Special (immediate Track) |
S019 |
2015-03-12 |
30-day Notice |
S018 |
2015-01-29 |
135 Review Track For 30-day Notice |
S017 |
2014-05-01 |
30-day Notice |
S016 |
2014-05-01 |
Real-time Process |
S015 |
2012-05-04 |
135 Review Track For 30-day Notice |
S014 |
2011-12-23 |
Special (immediate Track) |
S013 |
2011-06-20 |
Normal 180 Day Track No User Fee |
S012 |
2011-04-12 |
135 Review Track For 30-day Notice |
S011 |
2010-11-03 |
30-day Notice |
S010 | | |
S009 |
2010-08-04 |
Special (immediate Track) |
S008 |
2009-09-08 |
Special (immediate Track) |
S007 |
2009-05-15 |
Normal 180 Day Track No User Fee |
S006 |
2009-02-18 |
Normal 180 Day Track No User Fee |
S005 |
2007-09-19 |
Normal 180 Day Track No User Fee |
S004 |
2007-09-17 |
Real-time Process |
S003 |
2007-09-06 |
135 Review Track For 30-day Notice |
S002 |
2007-05-31 |
Normal 180 Day Track No User Fee |
S001 |
2007-01-03 |
Normal 180 Day Track |
NIH GUDID Devices